Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 303-306, May 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huggins, C.
Right arrow Articles by Dao, T. L-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggins, C.
Right arrow Articles by Dao, T. L-Y.

Lactation Induced by Luteotrophin in Women with Mammary Cancer. Growth of the Breast of the Human Male Following Estrogenic Treatment*

Charles Huggins and Thomas L-Y. Dao

( The Ben May Laboratory for Cancer Research, University of Chicago, Chicago 37, Ill.)

The breast of the human male can be induced to grow to a functionally mature state by the administration of estrogenic substances without additional exogenous steroid synergists. Spontaneous lactation was not observed in these men, but it was induced by luteotrophin.

The formation of milk in any amount by the breast is a criterion of functional maturity of the mammary epithelium. Luteotrophin induced the secretion of small amounts of milk in a group of women with mammary cancer and in a number of healthy women as well, and, in addition, in two human males to whom estrogenic substances had been administered for therapeutic purposes. Lactation did not occur in two normal males.

Many patients with carcinoma of the breast, even those in the 7th decade, secreted milk when the mammary gland was challenged with luteotrophin, despite the menopause and earlier removal of the ovaries; the primary mammary cancer in most of these women was adenocarcinoma. Other women with cancer of the breast failed to lactate when treated with luteotrophin; the primary neoplasm in most of these patients was undifferentiated.

A potential secretory capacity can be retained by the breasts of the human female in senility.

The prolonged administration of testosterone did not cause functional atrophy of mammary epithelium.

When lactation was induced in human beings, the secretion often persisted for many months; it lasted for 7 years in one man. In certain women with mammary cancer lactation ceased abruptly following the removal of the ovaries and adrenal glands, while in others it persisted. In three women with this persistent lactation, the secretion of milk was not stopped by the administration of diethylstilbestrol, testosterone, or progesterone.

* This study was aided by grants from the Jane Coffin Childs Memorial Fund for Medical Research, the American Cancer Society on recommendation of the Committee on Growth of the National Research Council, and the Damon Runyon Memorial Fund for Cancer Research.

Received 12/ 3/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.